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Objective: The objectives of this analysis were to examine how patients’ dependence on others 
relates to costs of care and explore the incremental effects of patient dependence measured by 
the Dependence Scale on costs for patients with Alzheimer’s disease (AD) in Spain.
Methods: The Co-Dependence in Alzheimer’s Disease study is an 18 multicenter, cross-
sectional, observational study among patients with AD according to the clinical dementia rating 
score and their caregivers in Spain. This study also gathered data on resource utilization for 
medical care, social care, caregiver productivity losses, and informal caregiver time reported 
in the Resource Utilization in Dementia Lite instrument and a complementary questionnaire. 
The data of 343 patients and their caregivers were collected through the completion of a clinical 
report form during one visit/assessment at an outpatient center or hospital, where all instru-
ments were administered. The data collected (in addition to clinical measures) also included 
sociodemographic data concerning the patients and their caregivers. Cost analysis was based on 
resource use for medical care, social care, caregiver productivity losses, and informal caregiver 
time reported in the Resource Utilization in Dementia Lite  instrument and a complementary 
questionnaire. Resource unit costs were applied to value direct medical-, social-, and indirect-
care costs. A replacement cost method was used to value informal care. Patient dependence 
on others was measured using the Dependence Scale, and the  Cumulative Index Rating Scale 
was administered to the patient to assess multi-morbidity. Multivariate regression analysis was 
used to model the effects of dependence and other  sociodemographic and clinical variables on 
cost of care.
Results: The mean (standard deviation) costs per patient over 6 months for direct medical-, 
social-, indirect-, and informal-care costs were estimated at €1,028.10 (€1,655.00), €843.80 
(€2,684.80), €464.20 (€1,639.00), and €33,232.20 (€30,898.90), respectively. Dependence 
was independently and significantly associated with direct medical-, social-, informal-, and 
total-care costs.
Conclusion: The costs of care for patients with AD in Spain are substantial, with informal 
care accounting for the greatest part. Interventions that reduce patient dependence on care-
givers may be associated with important reduction in direct medical-, social-, informal-, and 
total-care costs.
Keywords: Alzheimer, Dependence Scale, direct medical care costs, social care costs, indirect 
care costs, informal care costs.
Introduction
Alzheimer’s disease (AD), the most common cause of dementia, is a major cause of dis-
ability and care burden in the elderly.1,2 Over time, patients invariably develop cognitive 
and functional decline, and most develop behavioral disturbances sooner or later.3
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AD has been shown to cause a substantial burden on 
several levels including personal, emotional, financial, and 
social levels.4 In most countries, a substantial proportion of 
the total care costs of AD is absorbed by family members 
caring for patients at home.5 Declining cognitive and func-
tional abilities contributes increasingly to the patient’s loss 
of independent living and dependency.2,3
The relationship between a patients’ loss of function and 
a higher cost of care for patients with AD has been clearly 
demonstrated.2,6–9 To provide a full explanation of variation in 
AD-related costs and patients’ dependence on other individu-
als, the Dependence Scale (DS)10 was developed to directly 
measure the amounts of help AD patients require. Several 
studies have begun to examine the effect of dependence on 
costs of care.11–15 Although the effect of dependence is less 
well known, these studies provide support for the DS as an 
independent predictor of cost and suggest a positive rela-
tionship between increasing dependence and higher costs. 
Zhu et al8,9 found that dependence measured by the DS has 
an incremental effect on costs of care for patients with AD 
above the effects of function. This makes it very important 
to explore the effect of dependence and functional disability 
in dementia separately, and the effect of dependence on dif-
ferent cost components of care.
In this study, data on resource utilization for medical care, 
social care, caregiver productivity losses, and informal care-
giver time reported in the Resource Utilization in Dementia 
Lite instrument and a complementary questionnaire were 
collected for a sample of patients with AD in Spain over 
a period of 6 months. The objectives of this study were to 
examine how patients’ dependence on others relates to costs 
of care and to estimate the incremental effect of dependence 
on costs for patients with AD. By estimating these relation-
ships, we hope to provide useful information for future eco-
nomic evaluations and provide insights for decision-makers 
for the management of AD, patient support, and health care 
planning of resources.
Methods
Study sample
The Codep-AD study conducted in 2011–2012 was an 
18 multicenter, cross-sectional, observational study among 
patients with AD according to the Clinical Dementia  Rating 
(CDR) score and their caregivers in Spain. The data of 
343 patients and their caregivers were collected through the 
completion of a clinical report form during a one visit/assess-
ment at an outpatient center or hospital, where all instruments 
were administered.
Participants for the study for each of the 18 centers were 
identified at each individual center or hospital. Inclusion 
criteria required patients to have received a diagnosis of 
possible or probable AD according to the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition.16 
Probable or possible AD was diagnosed according to the 
NINCDS-ADRDA criteria.17 The severity of dementia for 
each patient was established by the global CDR scale score.18 
Other criteria included the presence of a reliable and trust-
worthy caregiver to accompany the patient during the study 
visit and the person responsible for helping the patient in 
their basic and instrumental needs of daily life and to provide 
supervision at home for a minimum of at least 10 hours per 
week. The caregiver need not to be a member of the family or 
live with the patient. All patients and responsible caregivers 
had to sign an informed consent form.
Patients were excluded from the study if they had comor-
bid illness, which was a significant independent cause of 
disability (eg, dense hemiplegia or Parkinson’s disease), 
had a clinical status that predicted an outcome of short-term 
mortality, if the clinical study investigator opined that the 
patient and caregiver were not able to comply with the study 
protocol or if patients were participating in a clinical trial. 
Local ethics approval was obtained for the study.
A range of data were collected for each participant 
via a case report form including medical assessments and 
structured questionnaires. All medical assessments were 
completed by a physician and a psychologist at the patient’s 
outpatient center or hospital. All remaining data on sociode-
mographic and other clinical details, health and social care 
utilization and caregiving hours, were collected via structured 
caregiver questionnaires. Summary statistics for sociodemo-
graphic characteristics and clinical related variables of the 
343 study participants are presented in Table 1.
Dependent cost variables
Five cost variables were identified, estimated, and examined 
in the statistical analysis. These included 1) medical care 
costs, 2) social care costs, 3) indirect care costs, 4) informal 
care costs, and 5) total care costs including all cost variables. 
Data on resources for the estimation of the five costs variables 
were obtained from the Resource Utilization in Dementia19 
Lite instrument and a complementary questionnaire which 
included aspects related to the utilization of resources not 
collected in the Resource Utilization in Dementia Lite 
questionnaire, both completed by the psychologist of the 
caregiver. This supplemental questionnaire included, among 
other aspects, modifications at home to improve the patients’ 
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Table 1 Sociodemographic variables and clinical characteristics
Variable Measure Number of 
observations
Patient-related variables
Sex – n (%) 342
 Male 113 (33.0%)
 Female 229 (67.0%)
age (years), mean (SD) 78.9 (7.4) 342
Place of residence – n (%) 341
 Own/family home 336 (98.5%)
 institutionalized 5 (1.5%)
Civil status – n (%) 342
 Married/partner 201 (58.8%)
 Others 141 (41.2%)
Years since diagnosis, mean (SD) 2.3 (2.3) 275
Caregiver-related variables  
Relation – n (%)
311
 Spouse 141 (45.3%)
 Others 170 (54.7%)
age (years), mean (SD) 60.4 (14.1) 342
Sex – n (%) 342
 Male 118 (34.5%)
 Female 224 (65.5%)
living with the patient – n (%) 342
 Yes 240 (70.2%)
 no 102 (29.8%)
Clinical characteristics
DS score, mean (SD) 8.0 (3.1) 338
DS score grouped – n (%) 338
 0–6 108 (32.0%)
 7–8 76 (22.5%)
 9–10 79 (23.4%)
 11–15 75 (22.2%)
CDR – n (%) 339
 0.5 18 (5.3%)
 1 116 (34.2%)
 2 102 (30.1%)
 3 103 (30.4%)
CiRS, mean (SD) 5.5 (4.0) 340
Abbreviations: CDR, Clinical Dementia Rating; CiRS, Cumulative illness Rating 
Scale; DS, Dependence Scale; n, number of patients; SD, standard deviation.
safety, transport costs of the patient, and pocket money for 
patient care.
Medical care costs were estimated for a set of resources 
including hospitalizations, emergency visits, diagnostic and 
monitoring tests, outpatient specialist visits, health and social 
care professional consultations, and health materials. Data 
on utilization over a 6-month period were collected and the 
total costs for medical care were estimated by applying a 
unit cost for each resource activity. Unit costs were derived 
from different local Spanish sources and expressed in € 2013. 
Prices were updated according to the consumer index by the 
Spanish National Institute for Statistics (Table 2).20
Social care costs were calculated from estimates of 
the number of nights living in an institutionalized setting, 
attendance of a day care center, number of complimentary 
services (day care at home, help at home, nurse home visits, 
meal delivery, transport services to day care center), and 
performed home modifications. Data on utilization were 
collected and the total costs for social care were estimated 
by applying a unit cost expressed in € 2013 (Table 2) for 
each resource activity in number of nights/days, received 
payments for home modifications, and number of services 
over the last 6 months.
Indirect care costs associated with lost productivity of the 
caregiver were calculated from estimates of reduced work-
ing hours per month and the loss of full and half working 
days per month. Unit costs for the loss of productivity were 
based on the national average wage per hour for a woman 
and man (% women/men 86.2%) of €11.98 obtained from 
Spanish National Institute for Statistics expressed in € 2013. 
The total care costs were estimated by applying the hourly 
average wage to the lost working hours over a 6-month period, 
whereas a half lost working day counted for 4 hours and a 
full working day for 8 hours.20
Informal care costs were calculated from estimates of 
caregiving hours provided by the primary and secondary 
caregivers for each patient. This includes the total number of 
hours dedicated to basic activities of daily living and instru-
mental activities of daily living over the previous month as 
well as supervision of the patient. The hours of care per task 
were summed to obtain an estimate of the daily caregiving 
hours per patient. As it is difficult to value informal care, a 
replacement cost approach21 was used to value and quantify 
the cost of informal caregiver time, whereby all care hours are 
costed at the level of remuneration required to hire an equiva-
lent  professional. For the replacement cost, the hourly rate for 
health care assistance at home of €15.71 per hour (€ 2013) 
was used. No distinction was made between employed and 
unemployed caregivers. The daily informal care cost per 
patient was calculated by multiplying total care hours by the 
hourly wage rate and extrapolated to obtain an estimate of 
informal care cost over a 6-month period. The total care costs 
including all cost variables were equal to the sum of all costs 
over a 6-month period. In case extreme values for some direct 
medical care costs were observed and in case misinterpreta-
tion of the type and number of resources was suspected, these 
resources were excluded to prevent overestimation of costs.
independent variables
The independent variables adopted in this analysis included 
a range of sociodemographic characteristics and clinical 
measures. Sociodemographic data included the patients’ age, 
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sex, years since diagnosis, and place of residence (institu-
tionalized vs carer).
The DS10 measured the amount of assistance patients with 
dementia required, due to impairments. The questionnaire was 
completed as a caregiver interview, consisting of 13 questions. 
The scores of the scale range between 0 and 15 and the scale 
is scored as a sum of items, with a higher score indicating 
more impairment and a greater dependence of the patient 
on a caregiver.
The Cumulative Illness Rating Scale (CIRS)22 was admin-
istered to the patient to assess multi-morbidity. The scale 
consists of 14 dimensions that allow the quantification of 
chronic conditions considering severity. The scale is scored 
as the sum for each dimension and although the score ranges 
between 0 and 56, very high scores are not plausible as they 
represent concurrent failure of multiple systems which are 
not compatible with life.
Statistical analysis
Descriptive statistics for the estimated costs of care are pre-
sented using univariate analysis of variance (ANOVA) tables 
in terms of the mean and standard deviation (SD) for the 
whole sample and stratified by categories of dependence in 
quartiles (DS: 0–6; DS: 7–8; DS: 9–10; DS: 11–15), with the 
first quartile representing the lowest level of dependence and 
the highest quartile the most severe level of dependence.
Multivariate generalized linear regression analyses were 
carried out to explore the effects of the independent variables 
on each of the five dependent cost variables. For comparative 
purposes upon request, the results from a range of alternative 
model specifications are available from the authors. In each 
case, the regression model included the following indepen-
dent variables: DS score, years since diagnosis, CIRS score, 
patients’ sex (0=Male; 1=Female), living in an institutional-
ized setting (0=No; 1=Yes), living with the caregiver (0=No; 
1=Yes), and the patients’ age.
In all analyses, the dependent cost variable was modeled 
in its untransformed scale. The regression coefficients for 
continuous independent variables showed estimates for the 
unit change in cost for a unit change in that variable. That is, 
for a unit increase in the explanatory variable, cost increases 
by 100 beta%. For dichotomous variables, the coefficient 
estimated the unit change in cost relative to the reference 
group for that variable. Statistical significance was explored 
for two levels at P,0.01 and P,0.05. The model compari-
son was based on log likelihood or cube root statistics. Data 
were analyzed with SPSS® version 18.0 for Windows (SPSS; 
Chicago, IL, USA).
Table 2 Unit cost estimates
Resource item Activity Unit cost (€)
Medical care
Hospital admission Per admission 458.89a
Emergency visit Per visit 222.40a
Diagnostic and monitoring tests
 Blood test Per test 18.00
 Vitamin B12 Per test 5.65
 Folic acid Per test 5.65
  Thyroid hormones T3,  
T4, and TSH
Per test 19.23
  Computerized axial  
tomography (CaT)
Per test 120.57
 liver tests Per test 1.17
  neuropsychological  
explorations
Per test 118.58
 Renal function Per test 0.61
 Syphilitic serologic Per test 15.39
 Urine analysis Per test 1.54
 Electrocardiography (ECg) Per test 11.00
 Chest X-ray Per test 14.25
 Electroencephalography (EEg) Per test 45.67
  nuclear magnetic  
resonance (nMR)
Per test 192.54
 HiV antibodies Per test 237.29a
 apoE4 Per test 72.2829
 lumbar puncture Per test 267.15
  Positron emission tomography (PET) Per test 556.31a
Medical visits
 Primary care visit Per visit 34.00
 geriatrics Per visit 68.8130
 neurology Per visit 68.8130
 Psychiatry Per visit 68.8130
 Physiotherapist Per visit 16.27
 Occupational therapist Per visit 21.50
 Social assistant Per visit 33.52
 Psychologist Per visit 69.95
Health material
 Wheelchair Per unit 247.32a
 Walkers Per pair 60.76a
 articulated bed Per unit 1,906.52a
 anti-bedsore mattresses Per unit 141.42
 Underpad Per unit 0.79
 Remote alarm Per unit 55.76
 Diapers Per unit 0.69
Social care
Day care Per visit 30.4831
Health care assistant (assistant living) Per visit 15.7131
Food delivery Per meal 3.6232
Home nurse Per visit 29.27
Transportation services Per km 0.86a
living in an institutionalized setting Per month 2,018.6131
Day care center Per visit 177.00
Indirect/productivity loss of employed caregiver
Hourly wage national level Per hour 11.9833
Informal care
Replacement cost: health care assistant Per hour 15.7131
Notes: aaverage of different costs provided by hospitals. Data was provided 
from the following hospitals: Hospital Zamora, Zamora, Castilla and léon, 2011: 
Hospital Santiago de Compostela, Santiago de Compostela, galicia, 2011: Hospital 
Elda, Elda, Valencia, 2011: Hospital de Elche, Elche, Valencia, 2011: Hospital Padre 
Menni, Santander, Cantabria, 2011: Hospital Santa Caterina, girona, Catalonia, 2012: 
instituto andaluz de neurociencia, Málaga, 2011.
Abbreviation: TSH, thyroid-stimulating hormone.
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Table 3 Resource use
Resource item Resource use in  
mean (SD) or n (%)
Medical care
Days hospitalized (over 6 months) 0.4 (0.6)
number of emergency services attended  
(over 6 months)
1.5 (1.5)
Diagnostic tests (over 6 months)
 Blood test 0.7 (0.8)
 Vitamin B12 0.4 (0.6)
 Folic acid 0.4 (0.6)
 Thyroid hormones T3, T4, and TSH 0.4 (0.5)
 Computerized axial tomography (CaT) 0.5 (0.5)
 liver tests 0.5 (0.8)
 neuropsychological explorations 0.4 (0.5)
 Renal function 0.6 (0.8)
 Syphilitic serologic 0.3 (0.5)
 Urinalysis 0.5 (0.9)
 Electrocardiography (ECg) 0.3 (0.5)
 Chest X-ray 0.3 (0.5)
 Electroencephalography (EEg) 0.1 (0.3)
 nuclear magnetic resonance (nMR) 0.1 (0.3)
 HiV antibodies 0.02 (0.14)
Monitoring tests (over 6 months)
 Blood test 1.1 (1.1)
 Vitamin B12 0.4 (0.5)
 Folic acid 0.4 (0.5)
 Thyroid hormones T3, T4, and TSH 0.4 (0.5)
 Computerized axial tomography (CaT) 0.3 (0.5)
 liver tests 0.3 (0.5)
 neuropsychological explorations 0.7 (0.5)
 Renal function 0.4 (0.6)
 Syphilitic serologic 0.2 (0.4)
 Urinalysis 0.6 (0.7)
 Electrocardiography (ECg) 0.4 (0.7)
 Chest X-ray 0.3 (0.8)
 Electroencephalography (EEg) 0.1 (0.3)
 nuclear magnetic resonance (nMR) 0.3 (0.5)
 Brain SPECT 0.1 (0.3)
 HiV antibodies 0.04 (0.19)
 apoE4 0.04 (0.21)
 lumbar puncture 0.02 (0.15)
 Positron emission tomography (PET) 0.01 (0.11)
Medical visits (over 6 months)
 Primary care 4.4 (7.5)
 geriatrics 0.08 (0.31)
 neurology 1.0 (0.7)
 Psychiatry 0.6 (1.4)
 Physiotherapist 1.5 (7.2)
 Occupational therapist 2.6 (15.6)
 Social assistant 0.1 (0.4)
 Psychologist 1.3 (5.9)
 Other 2.4 (7.9)
Health material (over 6 months)
 Wheelchair 23 (8.0%)
 Walkers 16 (5.6%)
 articulated bed 31 (10.8%)
 anti-bedsore mattresses 17 (6.1%)
 Underpad 46 (15.9%)
(Continued)
Table 3 (Continued)
Resource item Resource use in  
mean (SD) or n (%)
 Dressing materials 13 (4.6%)
 Remote alarm 31 (10.8%)
 Diapers 87 (28.8%)
 Diapers per day 6.0 (19.4)
Social care
Complementary services (over 6 months)
 Day care 18.6 (42.7)
 assisted living 12.3 (37.7)
 Food delivery 1.8 (14.8)
 Home nurse 0.5 (2.9)
 Transportation services 7.3 (27.0)
  number of nights/living in institutionalized 
setting (over 6 months)
36.6 (73.2)
 Home modifications (over 6 months) 68 (98.6%)
 attend to day center (over 6 months) 88 (26.3%)
 Distance to day center in km (over 6 months) 6.8 (28.6)
Indirect/productivity loss of employed 
caregiver
number of hours reduced (hours/week) 7.0 (7.8)
Complete workdays (8 hours/day)  
lost/last month
0.5 (1.1)
Partial workdays (4 hours/day)  
lost/last month
1.9 (5.3)
Informal care
Primary caregiver for basic aDls  
(hours/month)
101.4 (170.0)
Secondary caregiver for basic aDls  
(hours/month)
40.7 (94.8)
Primary caregiver for instrumental aDls  
(hours/month)
106.8 (153.4)
Secondary caregiver for instrumental aDls 
(hours/month)
45.3 (99.7)
Primary caregiver for patient monitoring  
(hours/month)
128.9 (198.9)
Secondary caregiver for patient monitoring  
(hours/month)
59.4 (123.9)
Abbreviations: aDls, activities of daily living; n, number of patients; SD, standard 
deviation; TSH, thyroid-stimulating hormone; SPECT, single photon emission 
computed tomography.
Results
The results of the descriptive statistics for medical and non-
medical resource utilization, lost caregiver working hours, and 
informal caregiving hours per day are presented in Table 3.
When all individual medical resources were summed and 
costed, the mean (SD) direct medical care costs per patient 
over 6 months were equivalent to €1,028.12 (€1,655.02) 
(Table 4). With respect to social care costs, indirect care 
costs due to productivity loss of the primary or/and second-
ary caregiver and informal care costs, the mean (SD) costs 
per patient for these cost variables over 6 months were esti-
mated to be €843.80 (€2,684.80), €464.20 (€1,639.00), and 
€33,232.20 (€30,898.90), respectively. Informal care costs 
showed to be the highest compared to the other cost variables. 
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Table 4 Summary of costs over previous 6 months
Cost  
variables
Number of  
observations
Cost (€ 2013)
Mean (SD) Median (IQR)
Direct medical  
care costs
343 1,028.12 (1,655.02) 530.80 (866.55)
Social care  
costs
343 843.85 (2,684.83) 0.02 (62.81)
indirect care 
costs
343 464.21 (1,639.01) 0.01 (0.02)
informal care 
costs
308 33,232.20 (30,898.92) 24,272.02 (42,134.24)
Total care costs 343 32,177.34 (31,836.95) 21,093.34 (43,201.84)
Abbreviations: iQR, interquartile range; SD, standard deviation.
When all cost variables were summed, the total overall mean 
(SD) cost per patient summed up to €32,177.30 (€31,836.90) 
over 6 months.
The average 6-month direct medical care costs, social 
care costs, indirect care costs, and informal care costs by DS 
score quartiles are presented in Table 5 and show that costs 
rise with greater levels of dependence. Statistic differences 
according to DS score quartiles were observed for direct 
medical-, social-, informal-, and total-care costs (P,0.001). 
No statistical differences were observed in indirect care costs 
according to DS score quartiles.
The results from the multivariate analyses are presented 
in Table 6. The results for direct medical-, social-, and 
informal-care costs showed that the independent variable 
which was statistically significant after controlling for other 
covariates with all these four dependent cost variables was 
the DS score. Specifically, each additional one-point increase 
in the DS score, that is a one-unit improvement in patients’ 
dependence, was associated with a 13.5% increase in direct 
medical care costs, a 25.3% increase in social care costs, 
and a 214.7% increase in informal care costs over 6 months 
significance (P=0.01). No other independent variable was 
statistically significant for four cost variables.
Regarding direct medical care costs, three independent 
variables reached statistical significance (P=0.01) in the 
regression analysis: DS score, years since diagnosis, and CIRS. 
A one-point increase in years since diagnosis was associated 
with a 15% (P=0.01) decrease in direct medical care costs over 
6 months. A one-point increase in CIRS score was associated 
with a 6.4% (P=0.01) increase in direct medical care costs 
over 6 months.
In respect to indirect care costs, the only independent 
variable which was statistically significant after controlling 
for other covariates was living with the caregiver. Living with 
the caregiver was associated with a 101.3% (P=0.05) decrease 
in indirect medical care costs over 6 months.
Regarding informal care costs, the independent variables 
which were statistically significant after controlling for other 
covariates were the DS score and living with the caregiver. 
Living with the caregiver was associated with a 270.2% 
(P=0.05) increase in informal care costs over 6 months. No 
other independent variable reached statistical significance 
associated with direct medical-, social-, indirect-, and 
informal-care costs.
In the summed total care costs analysis, both DS scores 
and sex were significantly associated with total care costs 
over 6 months. A one-point increase in the DS score was 
associated with a 185.6% (P=0.01) increase in total care 
costs, whereas being a woman lead to a 263.5% increase in 
total care costs over 6 months.
Comparing these results with those from alternative 
model specifications available upon request to the authors 
suggests that estimates for the effects of dependence on 
costs were consistent as the findings remained consistent 
across alternative model specifications. The observed cor-
relations give an indication of the variables that will be the 
most influencing and explanatory in the multivariate analysis. 
Regarding dependence, the only cost variable that is not sig-
nificantly correlated to quantitative clinical variables is the 
indirect care costs (supporting information). Multi-morbidity 
measured by CIRS was significant with all cost variables 
except with direct non-medical care costs.
Table 5 Resource use and costs results by DS score categories
Variable/analysis Direct medical  
care costs (€)
Social care  
costs (€)
Indirect  
care costs (€)
Informal care  
costs (€)
Total care  
costs (€)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
DS score 0–6 624.72 (927.62) 138.42 (1,174.72) 374.20 (1,754.42) 13,865.91 (18,283.65) 13,334.24 (18,173.95)
DS score 7–8 773.10 (1,009.94) 835.12 (2,893.40) 494.32 (1,601.22) 28,277.11 (23,039.32) 27,403.14 (23,392.70)
DS score 9–10 1,176.21 (1,413.43) 1,147.83 (3,123.94) 481.03 (1,376.85) 38,690.43 (29,892.31) 38,067.14 (31,011.92)
DS score 11–15 1,722.31 (2,729.53) 1,432.45 (3,059.80) 543.43 (1,811.84) 57,833.55 (33,612.82) 56,133.82 (37,284.33)
P-value P,0.001b,c,d P,0.001a–c,d P=0.9 P,0.001a–c,d,e P,0.001a–c,d,e
Notes: Unit costs are presented in € 2013. Statistic differences (Mann–Whitney with Bonferroni correction: level =0.05/6≅0.008). aDS score 0–6 and DS score 7–8; bDS score 
0–6 and DS score 9–10; cDS score 0–6 and DS score 11–15; dDS score 7–8 and DS score 11–15; eDS score 9–10 and DS score 11–15; No significant differences were found 
between second and third group (Mann-Whitney with Bonferroni correction: level = 0.05/6 ≅ 0.008).
Abbreviations: SD, standard deviation; DS, Dependence Scale.
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Table 6 Multivariate analysis results
Variable/
model
Direct 
medical 
care 
costs
Social 
care 
costs
Indirect 
care 
costs
Informal 
care  
costs
Total 
care 
costs
Beta Beta Beta Beta Beta
Constant 4.826** -2.304 -0.388 -0.266 -3.879
DS 0.135** 0.253** 0.052 2.147** 1.856**
Years since  
diagnosis
-0.150** 0.058 -0.009 -0.026 -0.105
CiRS 0.064** 0.020 -0.069 0.155 0.126
Sex
  Male (base  
category)
– – – – –
 Female -0.055 0.274 0.499 0.699 2.635*
living in institutionalized settinga
  no (base  
category)
– – – – –
 Yes -0.058 – -2.562 -2.805 5.593
living with caregiver
  no (base 
category)
– – – – –
 Yes -0.066 -0.319 -1.013* 2.702* 0.073
 age 0.006 0.015 0.021 0.092 0.142
Notes: *P=0.05; **P=0.01. aThe effect covariate was not analyzed for social care 
costs as these are part of these costs and highly dependent on the covariate. 
– indicates base category.
Abbreviations: CiRS, Cumulative illness Rating Scale; DS, Dependence Scale.
Discussion
This analysis presented the estimated resource utilization and 
costs of direct medical care, social care, productivity loss of 
caregivers, and informal care for a sample of patients with 
AD living in the community in Spain. The mean (SD) costs 
per patient over 6 months for direct medical-, social-, indi-
rect-, and informal-care costs were estimated to be €1,028.10 
(€1,655.00), €843.80 (€2,684.80), €464.20 (€1,639.00), and 
€33,232.20 (€30,898.90), respectively. Total combined mean 
(SD) costs per patient summed up to €32,177.30 (€31,836.90) 
over 6 months. The incremental effect of patient dependence 
on the five total cost care variables was also estimated, while 
controlling for other clinical measures and a range of other 
sociodemographic characteristics.
In general, we find that the cost results for the Spanish 
sample reflect those from recent studies12–15 conducted in 
different countries except from Spain with informal care 
being the most important component of costs of care. The 
sum of the total care costs also showed to increase in the cur-
rent study as patient DS increases and similar results were 
observed in the study by Gillespie et al12 and Knapp et al.15
In our study, we also found that patient dependence 
was associated with direct medical-, social-, informal-, and 
total-care costs. An increase in dependence was associated 
with an increase in these costs. Similar results were obtained 
by various studies8,23,24 showing that patients’ dependence 
provides an important contribution in explaining variations 
in health care cost in AD and those changes in dependence 
are associated with changes in costs of care. This confirms 
that dependence plays an independent role in explaining 
 variations in costs of care. Our results suggest that small 
changes in patient dependence may be associated with sig-
nificant differences in direct medical-, social-, informal-, and 
total-care costs. One-point increase in the DS score, that is a 
one-unit improvement in patients’ dependence, was associ-
ated with a 13.5% increase in direct medical care costs, a 
25.3% increase in social care costs, and a 214.7% increase 
in informal care costs over 6 months significance (P=0.01). 
We found that the cost increases as patient DS increases were 
primarily driven by increases in informal care as was also 
observed in the study by Gillespie et al;12 though in the study 
by Knapp et al,15 cost were primarily driven by increases in 
direct non-medical care costs.
Thus, interventions that enhance patient independence 
or delay patients’ dependence may be associated with cost 
savings as well as clinical benefits. However, it is important 
to evaluate the cost effectiveness of these interventions before 
introducing and implementing them in clinical practice. For 
the management of AD, patient support, and health care 
planning of resources, it is important for decision-makers 
to focus on these interventions.
Although the focus of the paper was to explore the 
impacts of dependence on cost, we also identified other sig-
nificant effects of CIRS, years since diagnosis, sex, and living 
with the carer on some of the different cost components. This 
may indicate that except dependence some of these other 
independent covariates have an effect on costs and are also 
drivers of some of the different cost components. As no data 
were collected on the socio-economic status of the patients, 
any relationship with patient dependence and its effect on 
costs could not be explored.
The strength of this study includes the use of a structured 
assessment procedure in which numerous validated instru-
ments are applied as well as the collection of a broad range 
of resources for each participant including direct medical 
care, social care, productivity loss of caregivers, and informal 
caregiver hours. The design of the study allowed us to carry 
out a comprehensive cost analysis.
Besides, this study also has several limitations that need to 
be considered when interpreting the results. First, participants 
with mild, moderate, and severe AD in our study sample were 
selected from different hospitals in various Spanish regions, 
and may represent a non-random sample of AD patients 
in the community. However, because patients were drawn 
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from multiple locations, generalizability of our findings is 
enhanced. Second, data on patients’ health care costs were 
reported by patients and caregivers of the patient. In several 
studies,25,26 it was shown that caregivers are able to  accurately 
report medical information of the patients they take care 
of. Although there is no reason to believe that patients or 
caregivers’ reports of patients’ health care utilization are 
inaccurate, differences in the interpretation on the type and 
number of resources could have influenced the cost outcomes. 
Here, it must be observed that extreme values for some direct 
medical care costs have been observed and excluded in case 
misinterpretation of the type and number of resources was 
suspected. It is also possible that there are additional costs 
beyond those collected in the study, which might not have 
been included. As reported in other studies,8,9 the existence 
of uncertainty in valuing informal care has been reported, 
which makes it complicated and controversial.27,28 Normally, 
informal caregiver time is not reimbursed or available in the 
market,17 which makes the valuation of caregiver time and 
results sensitive to the approach adopted. In our analysis, 
caregiver time was valued including the costs of active care 
tasks (ie, basic and instrumental activities of daily living) as 
well as supervision. For both resources, a replacement cost 
per hour to hire a professional health care assistant was used. 
Including supervision in the costing of informal care could 
have increased the contribution of informal care costs to the 
total and further increase its relative importance to other 
resources, as reported by Wimo et al.5 Another uncertainty 
in the assessment of informal care could be the overstate-
ments by some caregivers. Therefore, another limitation is 
that there may be some costs that might have been counted 
double since some caregivers may have decreased their hours 
of work in order to provide informal care giving. It is dif-
ficult to quantify the extension and therefore the effect on 
the reported outcomes, though it should be acknowledged 
as a limitation.
Finally, the process of the costing of resource activities was 
complicated by the lack of one data source for all unit cost 
data. All unit costs are best estimates of the cost per activity. 
Therefore, it was not possible to identify cost differences across 
different sites. Further investigation is necessary to examine 
whether variations in resource utilization and costs reflect 
regional differences or availability or access of services.
Conclusion
The findings from this study show that levels of depen-
dence for patients with AD were significantly associated 
with various components of the cost of care. We find that 
patient dependence is an important predictor of direct medi-
cal-, social-, informal-, and total-care costs. Consequently, 
interventions that enhance patient independence or delay 
patients’ dependence may be associated with cost savings in 
direct medical care, social care, and informal care. For the 
management of AD, patient support, and health care planning 
of resources, it is important for decision-makers to focus on 
these interventions.
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